Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Acecainide

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 34118-92-8, N-acetylprocainamide hydrochloride, Acecainide hcl, Napa, Asl 601, Asl-601
    Molecular Formula
    C15H24ClN3O2
    Molecular Weight
    313.82  g/mol
    InChI Key
    IYEWBJUCJHKLHD-UHFFFAOYSA-N
    FDA UNII
    B9K738KX14
    A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-acetamido-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
    2.1.2 InChI
    InChI=1S/C15H23N3O2.ClH/c1-4-18(5-2)11-10-16-15(20)13-6-8-14(9-7-13)17-12(3)19;/h6-9H,4-5,10-11H2,1-3H3,(H,16,20)(H,17,19);1H
    2.1.3 InChI Key
    IYEWBJUCJHKLHD-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCN(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C.Cl
    2.2 Other Identifiers
    2.2.1 UNII
    B9K738KX14
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Acecainide

    2. Acecainide Monohydrochloride

    3. Acetylprocainamide

    4. Hydrochloride, Acecainide

    5. Monohydrochloride, Acecainide

    6. N Acetylprocainamide

    7. N-acetylprocainamide

    2.3.2 Depositor-Supplied Synonyms

    1. 34118-92-8

    2. N-acetylprocainamide Hydrochloride

    3. Acecainide Hcl

    4. Napa

    5. Asl 601

    6. Asl-601

    7. 4-acetamido-n-(2-(diethylamino)ethyl)benzamide Hydrochloride

    8. Acecainide Hydrochloride [usan]

    9. Nsc-759312

    10. 4'-((2-(diethylamino)ethyl)carbamoyl)acetanilide Monohydrochloride

    11. 34118-92-8 (hcl)

    12. Mls000863278

    13. Asl601;acecainide Hydrochloride

    14. B9k738kx14

    15. N-acetylprocainamide (hydrochloride)

    16. Ncgc00093534-02

    17. Dsstox_cid_25748

    18. Dsstox_rid_81092

    19. Dsstox_gsid_45748

    20. Acecainide Hydrochloride (usan)

    21. Benzamide, 4-(acetylamino)-n-(2-(diethylamino)ethyl)-, Monohydrochloride

    22. Smr000059132

    23. Cas-34118-92-8

    24. Unii-b9k738kx14

    25. Sr-01000000030

    26. Einecs 251-831-2

    27. Opera_id_64

    28. Asl 601(acecainide)

    29. Mls000028843

    30. Mls001148141

    31. Schembl122991

    32. Spectrum2300154

    33. Chembl1256805

    34. Dtxsid1045748

    35. Pharmakon1600-02300154

    36. Bcp20733

    37. Tox21_111206

    38. Tox21_500009

    39. Acecainide Hydrochloride [mi]

    40. Nsc759312

    41. Akos015888341

    42. Tox21_111206_1

    43. Ccg-213649

    44. Lp00009

    45. Nsc 759312

    46. Acecainide Hydrochloride [mart.]

    47. N-acetylprocainamide Hydrochloride, 99%

    48. Ncgc00015072-10

    49. Ncgc00093534-01

    50. Ncgc00093534-03

    51. Ncgc00260694-01

    52. As-75674

    53. Db-048569

    54. Eu-0100009

    55. Ft-0639157

    56. A 5909

    57. A20512

    58. D02746

    59. N16908

    60. 4-acetamido-n-(2-(diethylamino)ethyl)benzamide Hcl

    61. J-019456

    62. Sr-01000000030-2

    63. Acedainide; N-acetylnovocainamide Hydrochloride; Napa

    64. Q27274550

    65. 4-acetamido-n-(2-(diethylamino)ethyl)benzamidehydrochloride

    66. N-acetylprocainamide Hydrochloride, >=99% (hplc), Powder

    67. 4-acetamido-n-[2-(diethylamino)ethyl]benzamide;hydrochloride

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 313.82 g/mol
    Molecular Formula C15H24ClN3O2
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count7
    Exact Mass313.1557047 g/mol
    Monoisotopic Mass313.1557047 g/mol
    Topological Polar Surface Area61.4 Ų
    Heavy Atom Count21
    Formal Charge0
    Complexity308
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Arrhythmia Agents

    Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)